drugset / Trial / NCT06414837
Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is being conducted to evaluate the efficacy, and safety of HR091506 tablets for treatment of gout with hyperuricemia in adults, and to compare the results with febuxostat tablets in the same doses.
Timeline
- Start
- 2024-06
- Primary completion
- 2026-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Febuxostat | Small molecule | 20 mg | — |
| Comparator | Febuxostat | Small molecule | 40 mg | — |
| Comparator | Febuxostat | Small molecule | 60 mg | — |
| Comparator | Febuxostat | Small molecule | 80 mg | — |
| Subject | HR091506 | Unknown | 20 mg | — |
| Subject | HR091506 | Unknown | 40 mg | — |
| Subject | HR091506 | Unknown | 60 mg | — |
| Subject | HR091506 | Unknown | 80 mg | — |